We are excited to announce the launch of our new, upgraded New York Proton Center website! Working with technology partner SilverTech, Inc. and digital content manager Susanna P., we created a new website that: * Showcases NYPC's unique identity * Provides a comprehensive and seamless user experience, with streamlined navigation * Provides patients, caregivers, and referring physicians with readily available information to find what they need as efficiently as possible * Offers site visitors additional meaningful content that reflects NYPC's role as an industry leader in proton therapy and radiation oncology * Reflects the outstanding patient experience provided by our team Please visit our new website at nyproton.com.
About us
The New York Proton Center is creating the gold standard for proton therapy, giving new hope to patients living with cancer. In partnership with leading academic medical centers—Memorial Sloan Kettering Cancer Center, Montefiore Health System, Mount Sinai Health System—the New York Proton Center brings together expert oncologists, clinical care teams, and researchers to improve cancer care and advance the clinical evidence for proton therapy.
- Website
-
https://www.nyproton.com/
External link for New York Proton Center
- Industry
- Medical Practices
- Company size
- 51-200 employees
- Headquarters
- New York, New York
- Type
- Partnership
- Founded
- 2019
Locations
-
Primary
225 E 126th St
New York, New York 10035, US
Employees at New York Proton Center
-
LeAnthony Mathews, RN, MBA-IT, MS-I, CPHIMS
Director of Clinical Applications
-
Melissa Weisstuch
Marketing & Communications Manager at New York Proton Center
-
Francis Yu
Medical Physicist at New York Proton Center
-
Pratiksha Moktan, MBA
Director of Strategic Operations at New York Proton Center
Updates
-
The NYPC team was honored to present two oral presentations and 10 poster presentations at this week’s annual meeting of the American Association of Physics in Medicine (AAPM). The meeting is the largest gathering of medical physics professionals, and we are grateful for the opportunity to present our groundbreaking research on FLASH radiotherapy and pencil beam proton therapy for various types of cancers. It was great to join our peers and hear key insights into how technology can be used for enhancing and optimizing care. #protontherapy #medicalphysics
-
-
We are excited to announce that two of our NYPC physicians have earned appointments to new leadership positions in the Particle Therapy Co-Operative Group (PTCOG)! Join us in congratulating Dr. Charles B. Simone, II, FASTRO, FACRO as the new Co-Chair of the Thoracic Subcommittee and Arpit Chhabra, MD as the new Co-Chair of the Skull Base, Central Nervous System, and Sarcoma Subcommittee. These well-earned appointments highlight NYPC’s continued leadership in the proton therapy field.
-
-
We are excited to share that Dr. Minglei Kang, one of NYPC’s medical physicists, earned Best Clinic Poster at the Annual Meeting of the Particle Therapy Co-Operative Group (PTCOG) last week in Singapore. Dr. Kang’s poster outlined research on FLASH stereotactic body radiation therapy – a technique that delivers ultra-high dose radiation in a fraction of a second and has the potential to drastically shorten treatment periods and also minimize effects to surrounding tissue. Dr. Haibo Lin, NYPC's Director or Medical Physics, accepted the award on behalf of Dr. Kang.
-
-
We’re proud to be a leader on the cutting edge of proton therapy innovation. Just last week, members of the NYPC team traveled to Singapore to present at the 62nd Annual Meeting of the Particle Therapy Co-Operative Group (PTCOG) and share their expertise with attendees from around the world. Our team of radiation oncologists, physicists, and radiation therapists presented at over a dozen sessions, chaired meetings, and earned Best Clinic Poster at the conference. NYPC is proud to be a leading voice on a range of critical research and issues that are helping shape and advance our field, and we are grateful for the opportunity to share at PTCOG. #protontherapy #particletherapy #radiationoncology
-
-
New research led by the New York Proton Center’s Dr. J. Isabelle Choi found that invisible ink tattoos (IITs) for radiation therapy alignment can improve long-term quality of life and emotional well-being for people with cancer. Many of the patients who participated in the largest prospective clinical trial of IITs to date are willing to pay more or travel farther to avoid the visible ink tattoos traditionally used in radiation therapy. Learn more about how this technology can help many patients put their cancer diagnosis behind them. #radiationoncology #protontherapy
-
Congratulations to our Research Associate, Xingyi Zhao, for winning first place in the 2024 Sal Vacirca Radiological and Medical Physics Society of New York (RAMPS) Young Investigator Symposium. Xingyi will represent RAMPS in the American Association of Physicists in Medicine Slam Competition during the AAPM annual meeting in Los Angeles.
-
-
Our Radiation Therapy team recently hosted staff from the American Society of Radiologic Technologists (ASRT) for a photoshoot in our Center. The photos featuring NYPC colleagues demonstrating set-up, positioning, and delivery of proton therapy, as well as CT simulation and PET-CT, will be used in the development of ASRT educational content for students and experienced technologists. Thank you to all who participated!
-
-
Our Chief Medical Officer, Dr. Charles B. Simone, II recently presented on chest reirradiation with SBRT.
A fruitfull presentation with the title "Optimizing Re-irradiation in the chest: the role of SBRT in locoregionally Recurrent Lung cancers" by Charles SIMONE in #ISRS2024 in New York. During his presentation he mention that: - systemic therapy progress, upgrade importancy of Local Control improvement. - repeat of #SBRT has an increasingly established role for early stage #NSCLC reccurences and could lead to LC and OS improvement - #Protontherapy with its physical advantage could better protect previous irradiated organ at risk - #Flash Protontherapy could be in the future the treatment of choice reducing both acute and late toxicity (but still under research)
-
-
Join our outstanding team!
Maria Ugarte, SHRM - SCP is #hiring. Know anyone who might be interested?